NR1I2 and neoplasm: Elevated PXR expression was significantly associated with advanced disease stage and increased tumor proliferative capacity, assessed by Ki-67 labelling index, in uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma [48].